Internal Radioactive Contamination —Development of Decorporation Agents
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 2, 2006
May 14, 2020
2c9ecc52-8f94-400c-a1be-8bf28a25e1a8
Related Documents
Nonclinical Safety Evaluation of Pediatric Drug Products
Guidance DocumentFebruary 15, 2006Center for Drug Evaluation and Research
Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency
Guidance DocumentJune 5, 2006Center for Drug Evaluation and Research
Prescription Drug Marketing Act — Donation of Prescription Drug Samples to Free Clinics
Guidance DocumentMarch 14, 2006Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.